Cargando…
Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV‐exposed infants in a randomized controlled trial, Botswana
INTRODUCTION: Despite declining risk of vertical HIV transmission, prophylactic cotrimoxazole (CTX) remains widely used to reduce morbidity and mortality in the event of HIV infection among exposed infants, with an inherent risk of conferring commensal antimicrobial resistance. Using data from a ran...
Autores principales: | Powis, Kathleen M, Souda, Sajini, Lockman, Shahin, Ajibola, Gbolahan, Bennett, Kara, Leidner, Jean, Hughes, Michael D, Moyo, Sikhulile, van Widenfelt, Erik, Jibril, Haruna B, Makhema, Joseph, Essex, Max, Shapiro, Roger L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810322/ https://www.ncbi.nlm.nih.gov/pubmed/29119726 http://dx.doi.org/10.1002/jia2.25021 |
Ejemplares similares
-
Similar HIV protection from four weeks of zidovudine versus nevirapine prophylaxis among formula-fed infants in Botswana
por: Powis, Kathleen M., et al.
Publicado: (2018) -
HIV-exposed children account for more than half of 24-month mortality in Botswana
por: Zash, Rebecca, et al.
Publicado: (2016) -
Are morbidity and mortality estimates from randomized controlled trials externally valid? A comparison of outcomes among infants enrolled into an RCT or a cohort study in Botswana
por: Thivalapill, Neil, et al.
Publicado: (2021) -
Detecting congenital malformations - Lessons learned from the Mpepu study, Botswana
por: Ajibola, Gbolahan, et al.
Publicado: (2017) -
Cotrimoxazole Prophylaxis and Risk of Severe Anemia or Severe Neutropenia in HAART-Exposed, HIV-Uninfected Infants
por: Dryden-Peterson, Scott, et al.
Publicado: (2013)